Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant in women with chronic cough and stress urinary incontinence
NCT04193176Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of gefapixant in chronic cough, sponsored by Merck & Co.. Started May 2020; status: completed.
02
Drugs
gefapixant
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT04193176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193176.